www.emcdda.europa.eu
Published on www.emcdda.europa.eu (http://www.emcdda.europa.eu)

Home > EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB)

EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB)

EMCDDA, Europol, Lisbon, September 2017

Summary

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}- 3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 3 July 2017.

Download as PDF
  • English (en) [1]

Table of contents

  • Introduction
  • Information collection process
  • Information required by Article 5.2 of the Council Decision
  • Information from the EMA (Article 5.3 of the Council Decision)
  • Conclusion
  • References

Keywords: 

chemistry [2] new psychoactive substances (NPS) [3] synthetic drugs [4]

cover page thumbnail
Pages: 
16
Price: 
Free
ISBN: 
978-92-9497-199-9
ISSN: 
1977-7868
Pub. DOI: 
10.2810/210307
Catalog Number: 
TD-AS-17-003-EN-N

Related links: 

  • EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA [5] 
  • Action on new drugs [6] 

Source URL: http://www.emcdda.europa.eu/publications/joint-reports/5F-MDMB-PINACA_en

Links
[1] http://www.emcdda.europa.eu/system/files/publications/5483/2017.4963_TDAS17003ENN_PDFWEB.pdf
[2] http://www.emcdda.europa.eu/keywords/chemistry_en
[3] http://www.emcdda.europa.eu/keywords/new-psychoactive-substances-nps_en
[4] http://www.emcdda.europa.eu/keywords/synthetic-drugs_en
[5] http://www.emcdda.europa.eu/publications/implementation-reports/2016
[6] http://www.emcdda.europa.eu/drug-situation/new-drugs